+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of the partricin derivative, IB-643, against systemic murine candidosis



Efficacy of the partricin derivative, IB-643, against systemic murine candidosis



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 469




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031200297

Download citation: RISBibTeXText


Related references

Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis. Journal of Antimicrobial ChemoTherapy 47(2): 183-186, 2001

Pharmacokinetics and tissue distribution of a new partricin A derivative (N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate) in mice. Journal of Pharmaceutical Sciences 91(5): 1252-1258, 2002

Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis. Antimicrobial Agents and ChemoTherapy 41(3): 706-708, 1997

Methyl-partricin in the treatment of candidosis of the oral cavity in infants. Controlled research. Minerva Pediatrica 27(36): 2030-2033, 1975

Evaluation of himachalol in murine systemic candidosis. Journal de Mycologie Medicale 9(4): 217-220, 1999

Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentralblatt fuer Bakteriologie 273(3): 391-403, 1990

Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. Journal of Leukocyte Biology 51(3): 305-306, 1992

Comparison of oral imidazoles in therapy of systemic candidosis in a murine model. Abstracts Of The Annual Meeting Of The American Society For Microbiology: Stract F1, 1984

Pharmacokinetics of a new derivative of partricin A (SPA-S-753) in rodents. ChemoTherapy 46(3): 153-159, 2000

Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs. ChemoTherapy 33(1): 52-60, 1987

Efficacy of SSY726 on systemic candidosis and cryptococcosis in neutropenic mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 113, 1996

Chemotherapy of chronic mucocutaneous candidosis and systemic candidosis treated by oral ketoconazole. Chemotherapie von Oberflachen , Organ und Systemmykosen I Deutsches Nizoral Symposium: 58-68, 1982

Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses 49(2): 104-108, 2006

In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis. Plos one 9(8): E103039, 2014

Therapeutic efficacy of GW 531920, a new azasordarin derivative, in systemic candidiasis in mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 389, 2000